Active Ingredient (In Each Tablet)
Ranitidine 75 mg (as ranitidine hydrochloride USP, 84 mg)
The following Structured Product Label (SPL) was submitted to the FDA by Chain Drug Consortium, Llc. for the product Ranitidine - Acid Reducer (NDC 68016-352). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, do not use, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Ranitidine 75 mg (as ranitidine hydrochloride USP, 84 mg)
Acid reducer
Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
colloidal silicon dioxide, croscarmellose sodium, hypromellose, iron oxide red, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, talc, titanium dioxide
call 1-800-406-7984
Read the directions, consumer information leaflet and warnings before use.
Keep the carton. It contains important information.
DISTRIBUTED BY
CHAIN DRUG CONSORTIUM
3301 NW BOCA RATON BLVD
SUITE 101, BOCA RATON, FL 33431
Premier Value®
NDC 68016-352-60
Ranitidine Tablets, USP 75 mg
Acid Reducer
Regular Strength
60 Tablets
Prevents & Relieves Heartburn Associated with Acid Indigestion & Sour Stomach
†Compare to the active ingredient of Zantac 75®
†This product is not manufactured or distributed by Boehringer Ingelheim Pharmaceuticals Inc., owner of the registered trademark Zantac 75®.
* Please review the disclaimer below.